Crosstalk between microRNA-122 and FOX family genes in HepG2 cells

被引:14
|
作者
Kumar, Subodh [1 ]
Batra, Ankita [1 ]
Kanthaje, Shruthi [1 ]
Ghosh, Sujata [1 ]
Chakraborti, Anuradha [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Expt Med & Biotechnol, Chandigarh 160012, India
关键词
microRNA-122; Fox family genes; apoptosis; hepatocellular carcinoma; NEGATIVE FEEDBACK LOOP; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION FACTOR; INDUCED APOPTOSIS; PROLIFERATION; METASTASIS; EXPRESSION;
D O I
10.1177/1535370216681548
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
MicroRNA-122 (miR-122) is liver specific and plays an important role in physiology as well as diseases including hepatocellular carcinoma (HCC). Downregulation of miR-122 in HCC modulates apoptosis. Similarly, the putative targets of miR-122, the forkhead box (FOX) family genes also play an important role in the regulation of apoptosis. Hence, an interplay between miR-122 and FOX family genes has been explored in this study. Initially, an augmentation of apoptosis was noticed in HepG2 cells after transfection with miR-122. Further, the predicted miR-122 targets, the FOX family genes (FOXM1b, FOXP1, and FOXO4) were selected via in silico analysis based on their role in apoptosis. We checked the expression of all these genes at transcript level after the transfection of miR-122 and found that the relative expression of FOXP1 and FOXM1b was significantly downregulated (p<0.005) and that of FOXO4 was upregulated (p<0.005). Thus, the finding indicates deregulation of these FOX genes as a result of miR-122 augmentation might be involved in the modulation of apoptosis.
引用
收藏
页码:436 / 440
页数:5
相关论文
共 50 条
  • [1] MicroRNA-122 mimic transfection contributes to apoptosis in HepG2 cells
    Huang, Hongyan
    Zhu, Yueyong
    Li, Shaoyang
    MOLECULAR MEDICINE REPORTS, 2015, 12 (05) : 6918 - 6924
  • [2] microRNA-122抑制肝肿瘤细胞HepG2的增殖研究
    罗兰云
    胃肠病学和肝病学杂志, 2016, 25 (12) : 1467 - 1470
  • [3] MicroRNA-122 downregulates Rho-associated protein kinase 2 expression and inhibits the proliferation of prostate carcinoma cells
    Liu, Hong
    Hou, Teng
    Ju, Wen
    Xing, Yifei
    Zhang, Xiaoping
    Yang, Jun
    MOLECULAR MEDICINE REPORTS, 2019, 19 (05) : 3882 - 3888
  • [4] CYP3A4 and microRNA-122 are involved in the apoptosis of HepG2 cells induced by ILs 1-decyl-3-methylimidazolium bromide
    Li, Ai-Ling
    Gao, Shan-Shan
    Guo, Meng-Long
    Jing, Chang-Qin
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2020, 34 (01)
  • [5] MicroRNA-122 targets genes related to liver metabolism in chickens
    Wang, Xingguo
    Shao, Fang
    Yu, Jianfeng
    Jiang, Honglin
    Gong, Daoqing
    Gu, Zhiliang
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 2015, 184 : 29 - 35
  • [6] Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells
    He, Jialin
    Zhao, Kai
    Zheng, Lu
    Xu, Zhizhen
    Gong, Wei
    Chen, Shan
    Shen, Xiaodong
    Huang, Gang
    Gao, Min
    Zeng, Yijun
    Zhang, Yan
    He, Fengtian
    MOLECULAR CANCER, 2015, 14
  • [7] MicroRNA-520c-3p Modulates Doxorubicin-Chemosensitivity in HepG2 Cells
    Ragheb, Mohamed A.
    Soliman, Marwa H.
    Elzayat, Emad M.
    Mohamed, Mervat S.
    El-Ekiaby, Nada
    Abdelaziz, Ahmed, I
    Abdel-Wahab, Abdel-Hady A.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2021, 21 (02) : 237 - 245
  • [8] Demonstration of the Presence of the "Deleted" MIR122 Gene in HepG2 Cells
    Hamad, Ibrahim A. Y.
    Fei, Yue
    Kalea, Anastasia Z.
    Yin, Dan
    Smith, Andrew J. P.
    Palmen, Jutta
    Humphries, Steve E.
    Talmud, Philippa J.
    Walker, Ann P.
    PLOS ONE, 2015, 10 (03):
  • [9] Differentially expressed genes of HepG2 cells treated with gecko polypeptide mixture
    Duan, Yi-Meng
    Jin, Ying
    Guo, Meng-Li
    Duan, Leng-Xin
    Wang, Jian-Gang
    JOURNAL OF CANCER, 2018, 9 (15): : 2723 - 2733
  • [10] MicroRNA profile changes in liraglutide treated steatotic HepG2 cells
    Shen, Yunfeng
    Liu, Meimei
    Chen, Chao
    Lai, Xiaoyang
    Zhang, Meiying
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (03): : 4856 - +